Bio-Rad Laboratories BIO reported its Q1 earnings results on Thursday, May 4, 2023 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Bio-Rad Laboratories missed estimated earnings by 5.65%, reporting an EPS of $3.34 versus an estimate of $3.54.
Revenue was down $23.22 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.14 which was followed by a 5.99% increase in the share price the next day.
Here's a look at Bio-Rad Laboratories's past performance:
Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
---|---|---|---|---|
EPS Estimate | 3.45 | 2.78 | 2.80 | 3.40 |
EPS Actual | 3.31 | 2.60 | 3.38 | 4.94 |
Revenue Estimate | 742.25M | 679.94M | 682.62M | 675.10M |
Revenue Actual | 730.29M | 680.80M | 691.10M | 700.06M |
To track all earnings releases for Bio-Rad Laboratories visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.